iShares iBonds Dec 2029 Term Corporate ETF (ARCA: IBDU)

Latest news for iShares iBonds Dec 2029 Term Corporate ETF (ARCA:IBDU)

The Fund will invest at least 80% of its assets in the component instruments of the Underlying Index, and (except during the last twelve months of the Funds operations) the Fund will invest at least 90% of its assets in fixed income securities of the types included in the Underlying Index that BFA believes will help the Fund track the Underlying Index. The Fund will invest no more than 10% of its assets in futures, options and swaps contracts that BFA believes will help the Fund track the Underlying Index as well as in fixed income securities other than the types included in the Underlying Index, but which BFA believes will help the Fund track the Underlying Index

iShares iBonds Dec 2029 Term Corporate ETF

Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) shares are trading higher by 10% to $45.92 in November following Donald Trump's win in the <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">2024 presidential election</a>, as investors expect that his policies will create a favorable environment for financial institutions. 
Trump's plans to expand on the 2017 Tax Cuts and Jobs Act, potentially lowering corporate tax rates further, would increase Bank of America's profitability. 
Reduced taxes allow the bank to retain more of its earnings, which can then be directed toward expanding lending, enhancing shareholder returns or investing in new financial products.
What To Know: Deregulation is another factor that could benefit Bank of America under Trump's leadership. Trump has previously advocated for loosening financial regulations, particularly those imposed by the Dodd-Frank Act, which would give Bank of America more operational flexibility and reduce compliance costs. 
Regulatory relief could support the bank's lending activities, making it easier to extend loans to both consumers and businesses. This is especially advantageous for Bank of America, one of the largest lenders in the U.S., as relaxed regulations could foster growth in its retail and commercial lending segments.
Read Also: <a href="https://www.benzinga.com/tech/24/11/41973572/ray-dalios-bridgewater-cuts-stake-in-microsoft-stock-by-20-is-big-tech-losing-its-shine">Ray Dalio&#8217;s Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?</a>
What Else: Trump's policies on trade and infrastructure investment are also likely to impact Bank of America positively. As the administration emphasizes economic growth through trade incentives and substantial infrastructure spending, demand for credit may increase as businesses look to finance expansions and infrastructure projects. 
For Bank of America, this could mean greater loan demand and increased fee income from advisory and investment banking services.
Finally, Trump's economic approach may lead to inflationary pressures, which could keep interest rates elevated. Higher rates would improve Bank of America's net interest margin, boosting earnings from loans. 
Altogether, Trump's tax, regulatory, and economic policies provide a positive outlook for Bank of America's growth and profitability, driving investor optimism in the stock following the election.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41979935/golden-years-for-ma-deals-ahead-under-trump-analysts-highlight-top-10-large-cap-candidates">Golden Years For M&amp;A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates</a>
<h2 class="wp-block-heading">How To Buy BAC Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Bank of America&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BAC has a 52-week high of $46.52 and a 52-week low of $29.20.

News

What's Going On With Bank Of America (BAC) Shares

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has soared since Donald Trump won the 2024 presidential election and Benzinga readers think that the momentum could carry into 2025 for the<a href="https://www.benzinga.com/news/management/24/11/41856784/elon-musks-wealth-tops-300-billion-as-teslas-market-cap-soars-above-1-trillion"> electric vehicle company.</a>
What Happened: Tesla CEO Elon Musk endorsed Trump for president in the 2024 election and helped campaign for his victory. While the move may have been risky, given Trump's past criticism of electric vehicles, it appears to have paid off for Tesla's stock price and analysts' <a href="https://www.benzinga.com/markets/24/11/41890944/tesla-the-most-undervalued-ai-name-in-the-market-in-our-view-says-dan-ives-trumps-win-a-game-changer">optimism for the future.</a>
Tesla stock closed at $251.44 on Nov. 5, the day of the 2024 presidential election. With Trump being declared the victor in the early morning hours, the stock opened at $284.67 on Nov. 6 and closed the day trading at $288.53, up 14.8%.
The stock was volatile in the after-hours trading markets and overnight trading market hours for brokers offering customers the option.
Since Election Day, the stock is up 29.2%, posting the majority of its +32.4% year-to-date gains over the last two weeks.
Benzinga recently polled readers to see if the momentum can continue and carry Tesla to new all-time highs.
"Will Trump and Musk's close ties help drive Tesla to new all-time highs in 2025?" Benzinga asked.
The results were:
<ul>
<li>Yes: 62%</li>
<li>No: 14%</li>
<li>Yes, Tesla will reach all-time high in 2025, but not because of Musk/Trump friendship: 24%</li>
</ul>
The poll found that the majority of readers think the friendship between Musk and Trump will take Tesla stock to all-time highs in 2025. Twenty-four percent of poll respondents think Tesla stock will hit all-time highs in 2025, but not due to Trump.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent111424">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: The biggest takeaway from the poll is that whether or not it's because of Trump and Musk being friends, 86% of readers believe Tesla stock will hit all-time highs in 2025.
The current all-time high for Tesla stock is $414.50, hit on Nov. 7, 2021. To reach the all-time high, which last occurred three years ago, Tesla stock would have to gain an additional 27.6% from today's share price of $324.96.
Trump has spoken negatively about electric vehicles many times in the past, and many believe that he will remove federal credits for American buyers of EVs.
While the ending of federal credits for consumers could hurt the overall electric vehicle sector, analysts see the move having a lower impact on Tesla due to its profitability and scale. Instead, the move could hurt Tesla's competition and improve the company's market share in the sector.
One item to watch is if Trump reverses course in his comments that he <a href="https://www.benzinga.com/general/politics/24/10/41298125/maybe-musk-missed-the-memo-trumps-plan-to-ban-autonomous-vehicles-could-sour-friendship">will ban autonomous vehicles</a> from the road. Trump recently made those comments around the same time that Tesla showed off its Cybercab at its We Robot event in California.
Tesla is betting big on robotaxis, and a government that isn't friendly toward the vehicles could harm Tesla's stock price and future growth.
Musk's friendship with Trump could also help his other companies, like social media platform X and space company SpaceX. While this won't be a positive for Tesla, it could help with Musk's companies overall and perhaps trickle down to brand awareness for Tesla and a more favorable environment for Musk in the United States overall.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/24/11/41958626/tesla-short-sellers-down-8-billion-since-2024-election-and-there-could-be-more-pain-ahead">Tesla Short Sellers Down $8 Billion Since 2024 Election — And There Could Be More Pain Ahead</a></li>
</ul>
The study was conducted by Benzinga from Nov. 6 through Nov. 7, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 112 adults.
Image created using artificial intelligence via Midjourney.

Politics

Exclusives

Trading Ideas

TSLA

If Tesla Stock Hits All-Time Highs In 2025, Will It Be Driven By Trump-Musk Relationship? Benzinga Readers Say This

Vermont-based ice cream manufacturer Ben &amp; Jerry&#8217;s, an independent subsidiary of Unilever plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>), has a long <a href="https://www.benzinga.com/markets/cannabis/24/04/38440644/ben-jerrys-wont-stop-fighting-until-theres-cannabis-legalization-and-justice-says-activism-lead">history of corporate activism</a>. Its latest round has brought it into conflict with its own parent company.
What Happened: On Wednesday, Ben &amp; Jerry&#8217;s filed a contract lawsuit against Unilever in the Southern District of New York. The federal lawsuit alleges that Unilever breached Ben &amp; Jerry&#8217;s autonomy over social justice activism, specifically its various statements in support of a cease-fire between the Israeli government and Hamas in <a href="https://www.benzinga.com/markets/asia/24/10/41405272/sinwar-death-marks-turning-point-in-gaza-war-netanyahu-says-its-the-beginning-of-the-end">the ongoing war</a>. Ben &amp; Jerry&#8217;s and Unilever hold agreements to allow the brand's independent board to make social justice activism decisions.
Unilever has not yet filed a response, but a spokesperson reacted to Ben &amp; Jerry&#8217;s lawsuit in an email to Benzinga.
&#8220;Our heart goes out to all victims of the tragic events in the Middle East,&#8221; the spokesperson said. &#8220;We reject the claims made by B&amp;J's social mission board, and we will defend our case very strongly. We would not comment further on this legal matter."
The Burlington-based company&#8217;s complaint alleges that Unilever &#8220;silenced&#8221; efforts to speak out in support of Palestine. Following Ben &amp; Jerry&#8217;s statement in 2023 in support of an Israel-Palestinian cease-fire, the London, England-based parent company allegedly threatened to dissolve its independent board and sue board members.
In addition, Unilever blocked Ben &amp; Jerry&#8217;s donations to Jewish Voice for Peace and the Council on American-Islamic Relations, two organizations in support of Palestinians, the ice cream brand alleges. 
Ben &amp; Jerry&#8217;s previously sued Unilever in 2022. The ice cream manufacturer had announced a <a href="https://www.benzinga.com/government/21/07/22048169/ben-jerrys-joins-bds-movement-to-boycott-west-bank-and-east-jerusalem">cessation of sales</a> in the occupied West Bank and East Jerusalem in protest of Israeli policy. Unilever subsequently sold Ben &amp; Jerry&#8217;s Israel license, something Ben &amp; Jerry&#8217;s said was done without permission.
Why It Matters: It is considered rare for a subsidiary to file a lawsuit against its own parent company.
<a href="https://www.wsj.com/business/unilever-plans-to-spin-off-ice-cream-unit-in-shake-up-affecting-7-500-jobs-c768e45f?mod=article_inline">According</a> to the Wall Street Journal, Unilever has considered selling off its ice cream brands, including Ben &amp; Jerry&#8217;s, Breyer&#8217;s and Popsicle. Unilever acquired Ben &amp; Jerry&#8217;s in 2000.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41979935/golden-years-for-ma-deals-ahead-under-trump-analysts-highlight-top-10-large-cap-candidates">Golden Years For M&amp;A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates</a></li>
</ul>
Photo via Shutterstock.

Equities

Legal

Global

Markets

Ben & Jerry's Sues Parent Company Unilever Over Alleged Gaza Protest Censorship

Investors with a lot of money to spend have taken a bearish stance on Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MRNA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 12 uncommon options trades for Moderna.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 41%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $381,093, and 5 are calls, for a total amount of $293,373.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $22.5 and $65.0 for Moderna, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1677.71 with a total volume of 5,741.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $22.5 to $65.0 over the last 30 days.
<h3>Moderna Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731611773_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$22.8</td>
<td>$22.25</td>
<td>$22.6</td>
<td>$22.50</td>
<td>$113.0K</td>
<td>2</td>
<td>50</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.96</td>
<td>$2.91</td>
<td>$2.96</td>
<td>$35.00</td>
<td>$73.1K</td>
<td>2.1K</td>
<td>363</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$0.84</td>
<td>$0.7</td>
<td>$0.84</td>
<td>$41.00</td>
<td>$65.5K</td>
<td>4.2K</td>
<td>2.0K</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$7.95</td>
<td>$7.8</td>
<td>$7.9</td>
<td>$40.00</td>
<td>$61.6K</td>
<td>180</td>
<td>132</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$1.19</td>
<td>$1.09</td>
<td>$1.18</td>
<td>$41.00</td>
<td>$61.3K</td>
<td>4.2K</td>
<td>1.1K</td>
</tr>
</tbody>
</table>

<h3>About Moderna</h3>
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Moderna Standing Right Now?</h3>
<ul>
<li>With a trading volume of 5,268,882, the price of MRNA is down by -1.86%, reaching $41.35.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 98 days from now.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

MRNA

Moderna's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bullish stance on Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AFRM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 14 uncommon options trades for Affirm Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 21%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $673,247, and 10 are calls, for a total amount of $1,814,684.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $40.0 to $85.0 for Affirm Holdings during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Affirm Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Affirm Holdings's substantial trades, within a strike price spectrum from $40.0 to $85.0 over the preceding 30 days.
<h3>Affirm Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731611768_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$5.9</td>
<td>$5.7</td>
<td>$5.71</td>
<td>$50.00</td>
<td>$1.2M</td>
<td>2.5K</td>
<td>2.2K</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$3.05</td>
<td>$50.00</td>
<td>$518.5K</td>
<td>2.8K</td>
<td>1.7K</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$15.5</td>
<td>$14.6</td>
<td>$15.08</td>
<td>$40.00</td>
<td>$150.8K</td>
<td>2.0K</td>
<td>100</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$17.1</td>
<td>$15.9</td>
<td>$16.75</td>
<td>$50.00</td>
<td>$134.0K</td>
<td>2.4K</td>
<td>112</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$0.49</td>
<td>$0.48</td>
<td>$0.48</td>
<td>$52.50</td>
<td>$67.0K</td>
<td>2.0K</td>
<td>1.9K</td>
</tr>
</tbody>
</table>

<h3>About Affirm Holdings</h3>
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.
Following our analysis of the options activities associated with Affirm Holdings, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Affirm Holdings</h3>
<ul>
<li>Currently trading with a volume of 5,482,048, the AFRM's price is down by -2.06%, now at $53.69. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 84 days.</li>
</ul>
<h3>Expert Opinions on Affirm Holdings</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $56.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Susquehanna keeps a Positive rating on Affirm Holdings with a target price of $57. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Affirm Holdings, which currently sits at a price target of $55. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Affirm Holdings, which currently sits at a price target of $56. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Affirm Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

AFRM

Market Whales and Their Recent Bets on AFRM Options

Investors with a lot of money to spend have taken a bullish stance on Upstart Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with UPST, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Upstart Hldgs.
This isn't normal.
The overall sentiment of these big-money traders is split between 55% bullish and 33%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $139,970, and 6 are calls, for a total amount of $316,748.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $80.0 for Upstart Hldgs over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Upstart Hldgs options trades today is 1367.62 with a total volume of 1,958.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Upstart Hldgs's big money trades within a strike price range of $45.0 to $80.0 over the last 30 days.
<h3>Upstart Hldgs 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731611763_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$23.1</td>
<td>$22.25</td>
<td>$23.01</td>
<td>$45.00</td>
<td>$92.0K</td>
<td>1.0K</td>
<td align="right">41</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$2.23</td>
<td>$2.07</td>
<td>$2.23</td>
<td>$65.00</td>
<td>$62.4K</td>
<td>2.3K</td>
<td align="right">458</td>
</tr>
<tr>
<td>UPST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$3.25</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$67.00</td>
<td>$58.6K</td>
<td>136</td>
<td align="right">244</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$20.35</td>
<td>$19.45</td>
<td>$19.81</td>
<td>$65.00</td>
<td>$49.5K</td>
<td>271</td>
<td align="right">25</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$2.23</td>
<td>$2.22</td>
<td>$2.23</td>
<td>$65.00</td>
<td>$45.7K</td>
<td>2.3K</td>
<td align="right">668</td>
</tr>
</tbody>
</table>

<h3>About Upstart Hldgs</h3>
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit and small dollar loans.
Following our analysis of the options activities associated with Upstart Hldgs, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Upstart Hldgs</h3>
<ul>
<li>Currently trading with a volume of 3,381,222, the UPST's price is down by -1.62%, now at $66.7. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 89 days.</li>
</ul>
<h3>Professional Analyst Ratings for Upstart Hldgs</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $66.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler has elevated its stance to Overweight, setting a new price target at $85. 
&#x2A; An analyst from JP Morgan upgraded its action to Neutral with a price target of $45. 
&#x2A; An analyst from Wedbush persists with their Neutral rating on Upstart Hldgs, maintaining a target price of $60. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Upstart Hldgs with a target price of $56. 
&#x2A; An analyst from Citigroup upgraded its action to Buy with a price target of $87. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Upstart Hldgs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

UPST

Check Out What Whales Are Doing With UPST

Evotec Shares Resume Trade

Gaxos.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GXAI#NASDAQ">GXAI</a>) shares are moving higher Thursday after the company&#8217;s board approved the purchase of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) as a <a href="https://www.benzinga.com/pressreleases/24/11/g41968875/gaxos-board-of-directors-approves-bitcoin-as-treasury-reserve-asset">treasury reserve asset</a>.
The Details: Gaxos.AI, an AI applications company, said its board of directors approved the purchase of up to $1 million in Bitcoin.
&#8220;As demand for Bitcoin grows and so does its acceptance as a major and primary asset class, we believe that Bitcoin will serve as a strong treasury reserve asset,&#8221; said Vadim Mats, CEO of Gaxos. 
&#8220;With recent approval of Bitcoin ETFs and growing support from institutional investors, it is a great addition to our treasury strategy. Its limited supply and inflation-resistant characteristics provide a functional store of value.&#8221;&nbsp;
The strategic move from Gaxos comes after <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41887406/bitcoin-shatters-87000-all-time-high-ethereum-up-5-dogecoin-blasts-through-0-30-for-20-gain-in-memorable-monday-trading-session">Bitcoin</a> soared to new all-time highs earlier this week. Bitcoin was trading around $89,000 at the time of writing, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
<h3 class="wp-block-heading">Is GXAI A Good Stock To Buy?</h3>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages &#8211; like <a href="https://www.benzinga.com/quote/GXAI">Gaxos.AI</a>&#8216;s page for example &#8211; there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. Gaxos.AI does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's <a href="https://www.benzinga.com/calendars/dividends">dividend calendar</a> for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/GXAI">Gaxos.AI</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
See Also: <a href="https://www.benzinga.com/news/earnings/24/11/41945626/whats-going-on-with-bitcoin-mining-stocks-mara-holdings-riot-platforms-and-cleanspark">What&#8217;s Going On With Bitcoin Mining Stocks MARA Holdings, Riot Platforms And CleanSpark?</a>
GXAI Price Action: At the time of publication, Gaxos.AI shares were up 11.1% at 1.61, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Image via Unsplash

Movers

$BTC

GXAI

What's Going On With Gaxos.AI Stock Thursday?

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling by more than 150 points on Thursday.
The Dow traded down 0.38% to 43,790.84 while the NASDAQ fell 0.34% to 19,166.29. The S&amp;P 500 also fell, dropping, 0.37% to 5,963.37.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41971544/jim-cramer-recommends-microsoft-praises-american-water-works-for-being-consistent">Jim Cramer Recommends Microsoft, Praises American Water Works For Being &#8216;Consistent&#8217;</a>
Leading and Lagging Sectors Information technology shares rose by 0.2% on Thursday.
In trading on Thursday, industrials shares fell by 1.4%.
Top Headline
U.S. crude oil inventories increased by 2.089 million barrels in the week ended Nov. 8, compared to market estimates of a 1.85 million gain.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>AgEagle Aerial Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#NYSE">UAVS</a>) shares shot up 129% to $3.68 after the company announced 17 new purchase orders for its eBee TAC drones from U.S. defense and security customers.</li>
<li>Shares of DLocal Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLO#NASDAQ">DLO</a>) got a boost, surging 16% to $10.48 after the company reported better-than-expected third-quarter revenue results.</li>
<li>AC Immune SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIU#NASDAQ">ACIU</a>) shares were also up, gaining 20% to $3.7503 after the company announced interim safety and immunogenicity data from the Phase 2 VacSYn clinical trial evaluating ACI-7104.056 for the treatment of patients with early Parkinson's disease.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Nuvectis Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCT#NASDAQ">NVCT</a>) shares dropped 40% to $6.35 after the company reported data from its Phase 1b study evaluating NXP800.</li>
<li>Shares of Sow Good Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOWG#NASDAQ">SOWG</a>) were down 58% to $4.1099 after the company reported worse-than-expected quarterly financial results.</li>
<li>Vislink Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VISL#NASDAQ">VISL</a>) was down, falling 32% to $4.4535 after the company reported worse-than-expected third-quarter financial results.</li>
</ul>
Commodities In commodity news, oil traded down 0.1% to $68.41 while gold traded down 0.4% at $2,575.60.
Silver traded down 0.4% to $30.555 on Thursday, while copper fell 0.2% to $4.0750.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 1.08%, Germany's DAX climbed 1.37% and France's CAC 40 gained 1.32%. Spain's IBEX 35 Index gained 1.29%, while London's FTSE 100 rose 0.51%.
Asia Pacific Markets
Asian markets closed lower on Thursday, with Japan's Nikkei 225 falling 0.48%, Hong Kong's Hang Seng Index falling 1.96%, China's Shanghai Composite Index dipping 1.73% and India's BSE Sensex falling 0.14%.
Economics
<ul>
<li>U.S. initial jobless claims declined by 4,000 from the previous week to 217,000 in the week ending Nov. 9, compared to market estimates of 223,000.</li>
<li>U.S. producer prices rose 0.2% month-over-month in October compared to a revised 0.1% gain in September and in-line with market expectations.</li>
<li>U.S. crude oil inventories increased by 2.089 million barrels in the week ended Nov. 8, compared to market estimates of a 1.85 million gain.</li>
</ul>
Now Read This: 
<ul>
<li>N<a href="https://www.benzinga.com/24/11/41971143/nvidia-to-rally-around-23-here-are-10-top-analyst-forecasts-for-thursday">vidia To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday</a></li>
</ul>

Earnings

Eurozone

Commodities

Intraday Update

ACIU

NVCT

SOWG

UAVS

VISL

S&P 500 Moves Lower; US Crude Oil Inventories Increase

<a href="https://truthsocial.com/@realDonaldTrump/posts/113482854385986466" title="https://truthsocial.com/@realDonaldTrump/posts/113482854385986466">https://truthsocial.com/@realDonaldTrump/posts/113482854385986466</a>

Macro Economic Events

Economics

Donald J. Trump Posts On Truth "I respect Jamie Dimon, of JPMorgan Chase, greatly, but he will not be invited to be a part of the Trump Administration. I thank Jamie for his outstanding service to our Country!"

Legendary investor Ken Fisher's hedge fund, Fisher Asset Management, grew the value of its portfolio by more than $14 billion dollars <a href="https://www.benzinga.com/personal-finance/24/09/41030896/why-ken-fisher-says-capital-preservation-could-cost-you-big-in-retirement">in the last quarter</a>.
Here's a look at the fund's most significant trades.  
Top Holdings: Fisher Asset Management reported approximately $244 billion in assets under management (AUM), according to an SEC<a href="https://www.sec.gov/Archives/edgar/data/850529/000085052924000012/xslForm13F_X02/primary_doc.xml"> filing</a>. 
Read Next: <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a>
The firm also added small amounts to each of its top five positions: 
<ul>
<li>Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)</li>
<li>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</li>
<li>NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</li>
<li>Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and </li>
<li>Alphabet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>). </li>
</ul>
Top Buys: Fisher Asset Management's top buy in terms of value was $2.09 billion in shares of the iShares 7-10 Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IEF#NASDAQ">IEF</a>) which provides targeted exposure to U.S. Treasury bonds with remaining maturities between seven and ten years. Treasury bonds are generally considered low-risk investments, which can help balance riskier assets in a diversified portfolio. 
The fund's second and third-largest buys were $850 million in shares of JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) and $490 million worth of shares of oil and natural gas producer ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>). 
Top Sells: The hedge fund's top sells by value were $1.35 billion in shares of the iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LQD#NYSE">LQD</a>), $750 million worth of Walt Disney Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) shares and $710 million in shares of Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>). 
New Holdings: One of the fund's most notable new holdings is Nu Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), a digital banking services provider also backed by Warren Buffett. Fisher Asset management opened a position in Nu Holdings with approximately 7.23 million shares valued at more than $98.7 million.&nbsp;
The hedge fund also took a $28.3 million new position in wealth manager UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) and opened a $17.2 million position in the iShares MSCI China A ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CNYA#BATS">CNYA</a>), which tracks an index composed of Chinese equities available to international investors.
Why It Matters: Hedge funds often use sophisticated investment strategies and have access to extensive research which can provide insights into emerging market trends. Individual investors can track hedge funds for investment ideas, successful strategies or compare their own performance against professional investors.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Image: Shutterstock

AAPL

AMZN

CNYA

GOOGL

iShares Trust Barclays 7-10 Year Treasury Bond Fund

MSFT

NVDA

Here's How Billionaire Ken Fisher's Hedge Fund Made $14 Billion Last Quarter

Evotec Shares Halted To The Upside; Stock Now 10.33%

HALO

Evotec Is Said To Attract Takeover Interest From Halozyme

Analysts' ratings for ZoomInfo Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated ZoomInfo Technologies and provided 12-month price targets. The average target is $11.38, accompanied by a high estimate of $15.00 and a low estimate of $8.50. Marking an increase of 11.02%, the current average surpasses the previous average price target of $10.25. 
<img src="https://www.benzinga.com/files/images/story/2024/1731611087_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of ZoomInfo Technologies by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Sell</td>
<td>$8.50</td>
<td>$7.00</td>
</tr>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$11.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$11.00</td>
<td>$10.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to ZoomInfo Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of ZoomInfo Technologies compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of ZoomInfo Technologies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into ZoomInfo Technologies's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ZI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on ZoomInfo Technologies analyst ratings.</a>
<h2>All You Need to Know About ZoomInfo Technologies</h2>
ZoomInfo Technologies Inc provides a go-to-market intelligence platform for sales and marketing teams. Its cloud-based go-to-market data and insights platform deliver comprehensive and high-quality intelligence and analytics to provide sales and marketing professionals with accurate information and insights on the organizations and professionals. Nearly all of its revenue is derived from the United States.
<h3>Understanding the Numbers: ZoomInfo Technologies's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, ZoomInfo Technologies faced challenges, resulting in a decline of approximately -5.54% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: ZoomInfo Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -8.37% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): ZoomInfo Technologies's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -1.26%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): ZoomInfo Technologies's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.36%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 0.76, ZoomInfo Technologies faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Key Takeaways From ZoomInfo Technologies Analyst Ratings

Teekay Tankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNK#NYSE">TNK</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $57.25, a high estimate of $72.00, and a low estimate of $46.00. A decline of 9.13% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1731611078_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Teekay Tankers among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Omar Nokta</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$60.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Ken Hoexter</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$46.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Ken Hoexter</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$51.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Omar Nokta</td>
<td>Jefferies</td>
<td>Maintains</td>
<td>Buy</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Teekay Tankers. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Teekay Tankers compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Teekay Tankers's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Teekay Tankers's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TNK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Teekay Tankers analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Teekay Tankers's Background</h2>
Teekay Tankers Ltd is a provider of marine services to the global oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: tanker and ship-to-ship transfer. The vast majority of its revenue comes from the tanker segment, which consists of crude oil and product tankers for different contracts.
<h3>Teekay Tankers: A Financial Overview</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Negative Revenue Trend: Examining Teekay Tankers's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -14.9% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 24.18%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Teekay Tankers's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.42%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.1%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.03.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Teekay Tankers: Insights From 4 Analyst Reviews

In the latest quarter, 4 analysts provided ratings for Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $3.38, a high estimate of $6.00, and a low estimate of $2.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 19.33%. 
<img src="https://www.benzinga.com/files/images/story/2024/1731611045_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of Angi's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Sheridan</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.50</td>
<td>$3.25</td>
</tr>
<tr>
<td>Daniel Kurnos</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$6.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Nicholas Jones</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$3.00</td>
<td>$3.25</td>
</tr>
<tr>
<td>Ygal Arounian</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.00</td>
<td>$3.25</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Angi. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Angi compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Angi's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Angi's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ANGI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Angi analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Angi's Background</h2>
Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. The Company has three operating segments namely, Ads and Leads that generate maximum revenue, Services, and International (Europe and Canada). The company operates under multiple brands that including Angi, HomeAdvisor, and Handy. The majority of the revenue is earned from the United States.
<h3>Angi: Financial Performance Dissected</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Decline in Revenue: Over the 3 months period, Angi faced challenges, resulting in a decline of approximately -10.37% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Communication Services sector.
Net Margin: Angi's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.19% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Angi's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.36% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Angi's ROA stands out, surpassing industry averages. With an impressive ROA of 0.2%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Angi's debt-to-equity ratio is below the industry average at 0.48, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANGI

Forecasting The Future: 4 Analyst Projections For Angi

Analysts' ratings for Paysafe (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSFE#NYSE">PSFE</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $21.0, a high estimate of $23.00, and a low estimate of $19.00. A 3.67% drop is evident in the current average compared to the previous average price target of $21.80. 
<img src="https://www.benzinga.com/files/images/story/2024/1731611036_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Paysafe by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Perlin</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$21.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Jason Kupferberg</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$19.00</td>
<td>$16.20</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Paysafe. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Paysafe compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Paysafe's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/PSFE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Paysafe analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Paysafe</h2>
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet, and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
<h3>Financial Milestones: Paysafe's Journey</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Paysafe showcased positive performance, achieving a revenue growth rate of 9.34% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Paysafe's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -0.33%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Paysafe's ROE stands out, surpassing industry averages. With an impressive ROE of -0.16%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Paysafe's ROA excels beyond industry benchmarks, reaching -0.03%. This signifies efficient management of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.88, caution is advised due to increased financial risk.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PSFE

Key Takeaways From Paysafe Analyst Ratings

This call to the Dave Ramsey Show starts with a 21-year-old woman ready to graduate with a finance degree and plans to start a life with her boyfriend in Texas.&nbsp;
Her boyfriend has a friend there who can offer him work and he's been suggesting they could move together for a fresh start. But there's one major issue – her boyfriend, who's not in school and works only 20 hours a week as a personal trainer, doesn't believe his finances are her business.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/100k-cd">$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</a></li>
</ul>
Dave Ramsey's response? "Warning, warning, warning!" he says, laughing but totally serious. "I work 20 hours a week and my money is none of your business – warning, warning, warning! The bells are going off in your head so loud that you can hardly speak around them, aren't they?" Ramsey <a href="https://www.benzinga.com/personal-finance/24/06/39439265/single-mom-with-1-3-million-from-divorce-cant-afford-8-000-monthly-rent-dave-ramsey-says-its-tim">points out all the red flags</a> bluntly, saying what many people might think but hesitate to say out loud.
Ramsey's got his alarms blaring because, from where he's sitting, this isn't just about whether they'll have the cash for a move. He's pointing out that when discussing building a life together, finances, work ethic and trust are all things you want lined up before making big commitments. He says the boyfriend's "I work 20 hours a week" attitude doesn't exactly scream stability.
Ramsey's advice is clear: don't uproot your life for someone unwilling to meet you halfway. "You're building your life around somebody you're not married to," he warns her, adding that there's no true commitment here – especially if her boyfriend's financial status is "none of her business." Ramsey's stance is that a real partner would be transparent about his plans and finances, especially if they are planning to move together.
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
More people are moving in together these days. Last year, a record 11 percent of unmarried Americans aged 18 to 24 were living with a partner, according to the latest U.S. Census Bureau figures. So, couples need to communicate and be on the same page – especially if they're unmarried and have <a href="https://www.benzinga.com/personal-finance/24/02/37234302/dave-ramsey-reveals-the-blunt-truth-to-a-woman-who-says-her-long-term-boyfriend-doesnt-want-to-m">no legal obligation to each other</a>.&nbsp;
The caller also mentions that she might not find someone else who treats her "so wonderfully." At this point, Ramsey cuts in with a reality check: "If he was working 60 hours a week, making $100,000 a year, showering you with gifts and asking you to marry him, that's treating you wonderfully. Not ‘come over here so I can lean on you because I don't work much.'"
Ramsey and his co-host expand on this, likening it to advice for a younger sister. If this caller were 30 and advising her 21-year-old sister, would she tell her to move for a guy who doesn't work full-time and isn't ready to share financial responsibilities? Not a chance.
See Also: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
Ramsey leaves her with a proverb as a final piece of advice: "A wise person sees danger ahead and avoids it, but a foolish person keeps going and gets into trouble."
Ramsey urges her to keep her options open and remember that there are plenty of potential partners out there who not only are nice but also <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">bring the financial responsibility</a> and work ethic she deserves.
Read Next:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a></li>
</ul>

Personal Finance

'Warning, Warning, Warning!': Dave Ramsey Sounds The Alarm On Caller's Plan To Move For A Boyfriend Only Working 20 Hours A Week

Comp En De Mn Cemig American Depositary Shares Halted, News Pending

In a <a href="https://www.interviewmagazine.com/culture/mike-tyson-tells-rosie-perez-how-a-shamanic-revelation-inspired-him-to-fight-jake-paul">conversation</a> with Interview Magazine, legendary boxer <a href="https://www.benzinga.com/topic/mike-tyson">Mike Tyson</a> opened up to actress and boxing aficionado Rosie Perez about his surprising return to the ring at age 58. But beyond <a href="https://www.benzinga.com/general/entertainment/24/06/39231357/jake-paul-mike-tyson-boxing-match-set-to-stream-on-netflix-with-new-date">his upcoming bout</a> against YouTuber-turned-boxer Jake Paul, it was Tyson's profound experiences with psychedelics that stole the show.
Tyson's experimentation with psychedelics, particularly the powerful substance known as "the toad", <a href="https://www.benzinga.com/topic/5-meo-dmt">5-MeO-DMT</a>, has become a key part of his journey toward self-discovery and healing. He credits the toad with transformative experiences that fundamentally altered his outlook on life, death and his own legacy.
<h3 class="wp-block-heading">The Toad: A Journey Beyond The Physical</h3>
Tyson recounts his first encounter with the psychedelic toad venom with a mix of awe and reverence. "You see a toad, you bust its puss, put it on like a mirror, and it gets hard. You rub it until it becomes fine sand, then you smoke it," he explains. The description may sound crude, but Tyson's experience was anything but. "Then you meet God," he says simply.
For Tyson, the psychedelic journey was not just a fleeting high, it was a life-changing spiritual experience. He describes a "spiritual death," where he felt his ego dissolve and confronted his deepest fears. "I was scared to death. It was the closest I've ever been to <a href="https://www.benzinga.com/markets/cannabis/24/08/40528986/psychedelic-trips-resemble-near-death-experiences-new-study-shows-what-does-it-mean">death without dying</a>," he confesses. But rather than leaving him traumatized, the experience brought a sense of peace. "Dying is beautiful. How could death be bad and life be beautiful? It's a contradiction."
Perez, apparently fascinated, pressed Tyson on the impact of these experiences. "Did you see God?" she asks. Tyson clarifies, "No, you don't see him. You feel him." It's an ineffable sensation, one that left the former heavyweight champion with a profound sense of interconnectedness and humility. "I realized I'm nothing, but I'm everything at the same time." 
<h3 class="wp-block-heading">Psychedelics As A Tool For Healing</h3>
Tyson's exploration of psychedelics began as part of a broader journey toward self-improvement and healing from his past traumas. He said he&#8217;s undergone over 80 sessions with the toad, each time peeling back layers of his psyche and facing parts of himself he once tried to ignore. "It was terrifying at first," he admits, "but now I can't live without it. It's become a part of my spiritual practice."
The boxer is not shy about the benefits he believes psychedelics have brought to his life, particularly when it comes to relationships. He shares that his wife, Kiki, has also tried the toad under the guidance of a shaman. "It's better when someone you love is with you," Tyson says. "Anything that helps me, I want to share with the people I love."
Perez, who has her own experiences with alternative treatments for mental health, expressed understanding and admiration. She noted how <a href="https://www.benzinga.com/topic/cannabis-legalization">legalizing cannabis</a> helped her find peace after years of struggling with anxiety. "I had never slept a full night until I smoked weed," Perez said, drawing a parallel between her journey and Tyson's exploration of psychedelics.
<h3 class="wp-block-heading">The Power Of Psychedelics Therapy</h3>
Tyson is a strong advocate for the potential <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">therapeutic benefits of psychedelics</a>, especially substances like 5-MeO-DMT, which have been used in indigenous ceremonies for centuries. He says these powerful compounds could help people confront their traumas and find inner peace. "If psychedelics became legal, we'd have a whole different perspective on life. Everybody might start loving each other, and we don't want that, do we?"
This tongue-in-cheek comment belies a deeper truth. Tyson views psychedelics as a gateway to self-awareness and healing, a tool that could transform society's approach to mental health. The former heavyweight champion, who once battled addiction and spent time in rehab, now credits the toad with helping him maintain sobriety and reconnect with his purpose.
"It's not about getting high," Tyson insists. "It's about dying with dignity, facing your fears, and realizing there's nothing to be afraid of." The psychedelic journey, he adds, teaches humility and acceptance in a way no other experience can.
<h3 class="wp-block-heading">Changing Narratives Around Psychedelics</h3>
Tyson's experiences reflect a broader cultural shift as psychedelics move from the fringes of society into the mainstream, embraced for their potential to treat mental health disorders like depression, PTSD and anxiety. With research institutions <a href="https://www.benzinga.com/topic/psychedelics-research">exploring the therapeutic potential of substances</a> like <a href="https://www.benzinga.com/topic/psilocybin">psilocybin</a> and <a href="https://www.benzinga.com/topic/mdma">MDMA</a>, Tyson's advocacy for 5-MeO-DMT aligns with growing interest in psychedelics as a legitimate form of medicine.
Perez, intrigued by Tyson's transformation, asks whether he thinks psychedelics should be legalized. "They don't want it to be legal because it would change everything," Tyson responds. He says that if more people experienced the profound insights he gained from psychedelics, it would lead to a more compassionate and connected world.
For Tyson, the lessons learned from psychedelics offer a way to confront the inevitable fear of death, to live life more fully and to find peace in a chaotic world. "Fear is your friend," he tells Perez. "Most people are not in control of their minds. Their mind is in control of them. The toad showed me how to change that."
<h3 class="wp-block-heading">A New Chapter In Tyson's Journey</h3>
As Tyson prepares for his highly anticipated fight against Jake Paul, it's clear that his return to the ring is about more than just boxing. It's about reclaiming his narrative and sharing the lessons he's learned from a life that has taken him to the highest peaks of fame and the lowest valleys of despair.
The former heavyweight champ now sees himself as a kind of spiritual guide, using his platform to share the transformative power of psychedelics. "Life isn't over yet," Tyson says with a grin. "We're still fighting. The toad helped me find peace, and that's something I want to share with everyone."
Cover image Leonard Zhukovsky / Shutterstock

Comments

iShares iBonds Dec 2029 Term Corporate ETF

News

Latest news for iShares iBonds Dec 2029 Term Corporate ETF (ARCA:IBDU)

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga